WallStreetZenWallStreetZen

NASDAQ: NAKA
Nakamoto Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NAKA

Based on 1 analyst offering 12 month price targets for Nakamoto Inc

Min Forecast
$0.50+89.39%
Avg Forecast
$0.50+89.39%
Max Forecast
$0.50+89.39%

Should I buy or sell NAKA stock?

Based on 1 analyst offering ratings for Nakamoto Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NAKA stock forecasts and price targets.

NAKA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-23

1 of 1

Forecast return on equity

Is NAKA forecast to generate an efficient return?

Company
-3.29%
Industry
-56.46%
Market
150.49%
NAKA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NAKA forecast to generate an efficient return on assets?

Company
-2.27%
Industry
10.03%
NAKA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NAKA earnings per share forecast

What is NAKA's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.05
Avg 2 year Forecast
-$0.04

NAKA revenue forecast

What is NAKA's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$29.4M+1,384.79%
Avg 2 year Forecast
$43.6M+2,101.46%
NAKA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NAKA revenue growth forecast

How is NAKA forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
1,384.79%
Industry
8.2%
Market
26.95%
NAKA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NAKA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NAKA vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
NAKA$0.26$0.50+89.39%Strong Buy
JYNT$8.70N/AN/A
AIRS$2.09N/AN/A
BTMD$1.88N/AN/A
DCGO$0.67$1.50+123.21%Hold
View Top Medical Care Facility Stocks

Nakamoto Stock Forecast FAQ

Is Nakamoto Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NAKA) stock is to Strong Buy NAKA stock.

Out of 1 analyst, 1 (100%) are recommending NAKA as a Strong Buy, 0 (0%) are recommending NAKA as a Buy, 0 (0%) are recommending NAKA as a Hold, 0 (0%) are recommending NAKA as a Sell, and 0 (0%) are recommending NAKA as a Strong Sell.

If you're new to stock investing, here's how to buy Nakamoto stock.

What is NAKA's earnings growth forecast for 2026-2027?

(NASDAQ: NAKA) Nakamoto's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 17.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,671.88%.

Nakamoto's earnings in 2026 is -$90,489,127.On average, 4 Wall Street analysts forecast NAKA's earnings for 2026 to be -$20,189,156, with the lowest NAKA earnings forecast at -$38,794,848, and the highest NAKA earnings forecast at $0.

In 2027, NAKA is forecast to generate -$15,702,677 in earnings, with the lowest earnings forecast at -$34,484,310 and the highest earnings forecast at $4,618,434.

What is NAKA's revenue growth forecast for 2026-2027?

(NASDAQ: NAKA) Nakamoto's forecast annual revenue growth rate of 1,384.79% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 26.95%.

Nakamoto's revenue in 2026 is $1,980,278.On average, 4 Wall Street analysts forecast NAKA's revenue for 2026 to be $12,932,935,689, with the lowest NAKA revenue forecast at $689,686,194, and the highest NAKA revenue forecast at $25,887,863,923.

In 2027, NAKA is forecast to generate $19,175,299,506 in revenue, with the lowest revenue forecast at $689,686,194 and the highest revenue forecast at $38,739,427,198.

What is NAKA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: NAKA) forecast ROA is -2.27%, which is lower than the forecast US Medical Care Facilities industry average of 10.03%.

What is NAKA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NAKA price target, the average NAKA price target is $0.50, with the highest NAKA stock price forecast at $0.50 and the lowest NAKA stock price forecast at $0.50.

The Wall Street analyst predicted that Nakamoto's share price could reach $0.50 by Feb 23, 2027. The average Nakamoto stock price prediction forecasts a potential upside of 89.39% from the current NAKA share price of $0.26.

What is NAKA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: NAKA) Nakamoto's current Earnings Per Share (EPS) is -$1.11. On average, analysts forecast that NAKA's EPS will be -$0.05 for 2026, with the lowest EPS forecast at -$0.09, and the highest EPS forecast at $0.00. In 2027, NAKA's EPS is forecast to hit -$0.04 (min: -$0.08, max: $0.01).

What is NAKA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: NAKA) forecast ROE is -3.29%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.